Co-administration of DTaP with COVID-19 mRNA vaccine in mice alters immune responses and induces increased protection from Bordetella pertussis challenge
ABSTRACT During the COVID-19 pandemic, children received COVID-19 mRNA vaccines alongside other regularly scheduled immunizations, such as the acellular Bordetella pertussis vaccine DTaP. It is known that mRNA vaccines are pro-inflammatory in nature, leading to protective immunity against SARS-CoV-2 infection. The goal of this study was to investigate the potential adjuvanticity of co-administration of a COVID-19 mRNA vaccine alongside DTaP. Mice were immunized with DTaP alone or with a co-administration of DTaP plus COVID-19 mRNA vaccine. To understand the impact of co-administration, we evaluated protection against B. pertussis aerosol challenge in mice and potential correlates of protection, including cytokine responses to vaccination, antibody responses, and single-cell transcriptomic analysis of the draining lymph node. Three decreasing doses of each vaccine were used to simulate waning immunity. Overall, compared to mice immunized with DTaP, co-administration of DTaP + COVID-19 mRNA vaccines elicited higher pro-inflammatory cytokine responses, higher IgG2b antibody responses, and mice were afforded increased protection against aerosol challenge of B. pertussis . Single-cell transcriptomics studies on the lymph node of vaccinated mice at 1 day post-boost further characterized how co-administration of COVID-19 mRNA vaccine alongside DTaP vaccine shapes immunity. Single-cell transcriptomics revealed that co-administration of DTaP and COVID-19 mRNA vaccine generated populations of B and T cells with upregulated expression of interferon-stimulated genes, which were absent when vaccinating with DTaP alone. Altogether, these data suggest that administering DTaP alongside COVID-19 mRNA vaccine alters immune responses and provides increased protection from an aerosol challenge of B. pertussis compared to DTaP alone in mice.
Authors
- Graham J. Bitzer (ORCID: https://orcid.org/0000-0002-9734-6424)
- Dylan T. Boehm (ORCID: https://orcid.org/0000-0002-5329-1927)
- Kelly L. Weaver (ORCID: https://orcid.org/0000-0002-6954-2479)
- Nathaniel A. Rader (ORCID: https://orcid.org/0000-0002-6134-3133)
- Joshua A. Chapman
- Spencer R. Dublin (ORCID: https://orcid.org/0000-0001-6669-1519)
- Mariette Barbier (ORCID: https://orcid.org/0000-0002-3250-3636)
- Emel Sen-Kilic (ORCID: https://orcid.org/0000-0003-1583-2056)
- Annalisa Bison Huckaby (ORCID: https://orcid.org/0000-0003-2044-1535)
- Fredrick Heath Damron (ORCID: https://orcid.org/0000-0002-3140-402X)
- Carleena M. Rocuskie-Marker (ORCID: https://orcid.org/0000-0003-0644-6997)
- Casey Cunningham
- Melissa Cooper
- Katherine Lee
- Yegor S. Bushnev
Institutions
- West Virginia University (US)
- Embry-Riddle Aeronautical University Daytona Beach Florida Campus (US)
- Embry–Riddle Aeronautical University (US)
Publication Details
- Journal
- Infection and Immunity
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1128/iai.00065-26
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- West Virginia University
- National Institutes of Health
- National Institute of General Medical Sciences